Published in Proc Natl Acad Sci U S A on February 01, 1994
Alternative poly(A) site selection in complex transcription units: means to an end? Nucleic Acids Res (1997) 5.64
Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J (1995) 3.56
SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs. EMBO J (2001) 3.55
The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation. EMBO J (1997) 2.43
Regulation of gene expression for translation initiation factor eIF-2 alpha: importance of the 3' untranslated region. Biochem J (1996) 1.24
Characterization of multiple alternative RNAs resulting from antisense transcription of the PR264/SC35 splicing factor gene. Nucleic Acids Res (1997) 1.08
Characterization of SRp46, a novel human SR splicing factor encoded by a PR264/SC35 retropseudogene. Mol Cell Biol (1998) 1.01
The beta 1 subunit mRNA of the rat brain Na+ channel is expressed in glial cells. Proc Natl Acad Sci U S A (1994) 0.80
Alteration of C-MYB DNA binding to cognate responsive elements in HL-60 variant cells. Mol Pathol (2002) 0.75
A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell (1986) 36.96
Factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus. Nature (1990) 8.79
SR proteins: a conserved family of pre-mRNA splicing factors. Genes Dev (1992) 8.60
Distinct functions of SR proteins in alternative pre-mRNA splicing. Science (1993) 4.79
General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5' and 3' splice site selection. Proc Natl Acad Sci U S A (1992) 3.97
Isolation of a complementary DNA that encodes the mammalian splicing factor SC35. Science (1992) 3.52
Genetic complementation reveals a novel regulatory role for 3' untranslated regions in growth and differentiation. Cell (1993) 3.16
Regulated mRNA stability. Annu Rev Genet (1990) 2.93
A potential splicing factor is encoded by the opposite strand of the trans-spliced c-myb exon. Proc Natl Acad Sci U S A (1992) 2.05
Sex determination compared in Drosophila and Caenorhabditis. Nature (1990) 2.02
Structure and expression of the Drosophila melanogaster gene for the U1 small nuclear ribonucleoprotein particle 70K protein. Mol Cell Biol (1990) 1.85
In vivo splicing of the beta tropomyosin pre-mRNA: a role for branch point and donor site competition. Mol Cell Biol (1992) 1.24
Analysis of the expression of the 4F2 surface antigen in normal and neoplastic fibroblastic human cells of embryonic and adult origin. Exp Cell Res (1985) 1.00
The PR264/c-myb connection: expression of a splicing factor modulated by a nuclear protooncogene. Proc Natl Acad Sci U S A (1992) 0.97
Messenger RNA. Springtime in the desert. Nature (1993) 0.95
C-myb proto-oncogene: evidence for intermolecular recombination of coding sequences. Oncogene (1991) 0.93
Intermolecular recombination of the c-myb proto-oncogene coding sequences in chicken: clues for a mechanism. C R Acad Sci III (1990) 0.92
Length polymorphism in the 3' noncoding region of rat hepatic alpha 2u-globulin mRNAs. Biochim Biophys Acta (1987) 0.87
Single chicken cardiac myosin alkali light-chain gene generates two different mRNAs by alternative splicing of a complex exon. J Mol Biol (1988) 0.84
Nucleotide sequence of the transforming gene of avian myeloblastosis virus. Science (1982) 3.12
Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol (1992) 3.11
A potential splicing factor is encoded by the opposite strand of the trans-spliced c-myb exon. Proc Natl Acad Sci U S A (1992) 2.05
Proposal for a unified CCN nomenclature. Mol Pathol (2003) 1.98
Avian myeloblastosis virus transforming gene is related to unique chicken DNA regions separated by at least one intervening sequence. J Virol (1982) 1.97
novH: differential expression in developing kidney and Wilm's tumors. Am J Pathol (1998) 1.90
Acute leukemia viruses E26 and avian myeloblastosis virus have related transformation-specific RNA sequences but different genetic structures, gene products, and oncogenic properties. Proc Natl Acad Sci U S A (1982) 1.82
Growth control in simian virus 40-transformed rat cells: temperature-independent expression of the transformed phenotype in tsA transformants derived by agar selection. J Virol (1978) 1.81
Structural analysis of the human nov proto-oncogene and expression in Wilms tumor. Oncogene (1994) 1.40
Transcriptional down regulation of the nov proto-oncogene in fibroblasts transformed by p60v-src. Mol Cell Biol (1996) 1.39
Virus specified enzyme activity and RNA species in herpes simplex virus type 1 transformed mouse cells. J Gen Virol (1976) 1.38
Physical mapping of human loci homologous to the chicken nov proto-oncogene. Oncogene (1992) 1.26
Expression of the human NOV gene in first trimester fetal tissues. Anat Embryol (Berl) (2001) 1.23
Biologically active proviral clone of myeloblastosis-associated virus type 1: implications for the genesis of avian myeloblastosis virus. J Virol (1985) 1.23
A role for CCN3 (NOV) in calcium signalling. Mol Pathol (2002) 1.22
CCN proteins are distinct from, and should not be considered members of, the insulin-like growth factor-binding protein superfamily. J Clin Endocrinol Metab (2001) 1.21
Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues. Mol Pathol (2001) 1.19
Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation. J Cell Biochem (2007) 1.19
Downregulation of CCN3 expression as a potential mechanism for melanoma progression. Oncogene (2007) 1.19
The CCN family of genes: a brief history. Mol Pathol (2001) 1.18
Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol (2001) 1.15
Biosynthesis of Escherichia coli aspartate transcarbamylase. I. Parameters of gene expression and sequential biosynthesis of the subunits. J Mol Biol (1972) 1.14
The expression of ccn3 (nov) RNA and protein in the rat central nervous system is developmentally regulated. Mol Pathol (2001) 1.14
Chromosomal mapping and expression of the human cyr61 gene in tumour cells from the nervous system. Mol Pathol (1997) 1.13
Characterization of the expression of cellular retrovirus genes and oncogenes in feline cells. Hematol Oncol (1984) 1.12
Differential expression of novH and CTGF in human glioma cell lines. Clin Mol Pathol (1996) 1.11
Regulation of nov by WT1: a potential role for nov in nephrogenesis. Oncogene (1996) 1.10
Patterns of specific genomic alterations associated with poor prognosis in high-grade renal cell carcinomas. Cancer Genet Cytogenet (2001) 1.09
A developmental study of novH gene expression in human central nervous system. C R Acad Sci III (1998) 1.09
Characterization of multiple alternative RNAs resulting from antisense transcription of the PR264/SC35 splicing factor gene. Nucleic Acids Res (1997) 1.08
Characterization of SRp46, a novel human SR splicing factor encoded by a PR264/SC35 retropseudogene. Mol Cell Biol (1998) 1.01
Organization of chicken DNA sequences homologous to the transforming gene of avian myeloblastosis virus. I. Restriction enzyme analysis of total DNA from normal and leukemic cells. J Virol (1982) 0.99
Report and abstracts on the first international workshop on the CCN family of genes. Mol Pathol (2001) 0.99
CCN proteins are distinct from and should not be considered members of the insulin-like growth factor-binding protein superfamily. Endocrinology (2000) 0.98
CCN3 is a novel endogenous PDGF-regulated inhibitor of glomerular cell proliferation. Kidney Int (2007) 0.97
Immunocytochemical localization of NOVH protein and ultrastructural characteristics of NCI-H295R cells. J Submicrosc Cytol Pathol (2001) 0.97
The PR264/c-myb connection: expression of a splicing factor modulated by a nuclear protooncogene. Proc Natl Acad Sci U S A (1992) 0.97
Host-virus interactions critical for cellular transformation by polyoma virus and SV40. Cold Spring Harb Symp Quant Biol (1980) 0.97
Induction of nephroblastoma by myeloblastosis-associated virus type 1: state of proviral DNAs in tumor cells. J Virol (1989) 0.95
C-myb proto-oncogene: evidence for intermolecular recombination of coding sequences. Oncogene (1991) 0.93
Avian myeloblastosis virus: a model for the generation of viral oncogenes from potentially oncogenic cellular genetic elements. Folia Biol (Praha) (1983) 0.92
Genomic structure and chromosomal mapping of the mouse nov gene. Genomics (1996) 0.89
[Genetic alterations associated with pathologic differentiation of Wilms' tumors]. Bull Cancer (1997) 0.88
Pathogenic potential of myeloblastosis-associated virus: implication of env proteins for osteopetrosis induction. Virology (1993) 0.88
A novel type of RNA-binding protein is potentially encoded by the opposite strand of the trans-spliced c-myb coding exon. C R Acad Sci III (1991) 0.88
Transformation of Brown Leghorn chicken embryo fibroblasts by avian myeloblastosis virus proviral DNA. J Virol (1985) 0.87
The expression of chicken NOV, a member of the CCN gene family, in early stage development. Brain Res Gene Expr Patterns (2001) 0.87
Expression of a gene encoding a novel potential IGF binding protein in human tissues. C R Acad Sci III (1991) 0.86
Distinct transformation phenotypes induced by polyoma virus and simian virus 40 in rat fibroblasts and their control by an early viral gene function. J Virol (1980) 0.86
[Relationships between learning and memory and expression of nov gene of rats]. Sheng Li Xue Bao (2000) 0.85
Intermolecular recombination of human c-myb proto-oncogene coding sequences. C R Acad Sci III (1991) 0.84
Organization of 5'-proximal c-myb exons in chicken DNA. Implications for c-myb tissue-specific transcription. FEBS Lett (1988) 0.84
Two c-myb proteins differing by their aminotermini exhibit different transcriptional transactivation activities (yeast/reporter-effector system). Oncogene (1991) 0.83
The specificity of transcription in vitro of the tryptophan operon of Escherichia coli. II. The effect of Rho factor. Mol Gen Genet (1974) 0.83
Report and abstracts of the 3rd International Workshop on the CCN Family of Genes. St Malo, France, 20-23 October 2004. J Clin Pathol (2005) 0.82
Nucleotide sequence and organization of the transforming region and large terminal redundancies (LTR) of avian myeloblastosis virus (AMV). J Cell Biochem (1982) 0.80
Chromosomal reallocation of the chicken c-myb locus and organization of 3'-proximal coding exons. FEBS Lett (1990) 0.79
Assignment of the chicken NOV gene (alias CCN3) to chromosome 2q34-->q36: Conserved and compared synteny between avian, mouse and human. Cytogenet Genome Res (2002) 0.78
Avian myeloblastosis provirus cloned in a lambda bacteriophage is leukemogenic. J Virol (1982) 0.78
Report on the fourth international workshop on the CCN family of genes. J Cell Commun Signal (2007) 0.78
Incorporation of amino acid analogs during the biosynthesis of Escherichia coli aspartate transcarbamylase. Biochim Biophys Acta (1980) 0.78
Report on the fifth international workshop on the CCN family of genes. J Cell Commun Signal (2009) 0.78
Biosynthesis of Escherichia coli aspartate transcarbamylase. II. Correlated biosynthesis of the catalytic and regulatory chains and cytoplasmic association of the subunits. J Mol Biol (1977) 0.78
A protein of Halobacterium halobium immunologically related to the v-myc gene product. FEBS Lett (1988) 0.78
Retroviral insertional activation of the c-myb proto-oncogene in a Marek's disease T-lymphoma cell line. J Virol (1996) 0.77
Expression of a truncated v-myb product in transformed chicken embryo fibroblasts. FEBS Lett (1987) 0.77
Expression and synthesis of insulin-like growth factor (IGF)-I, -II and their receptors in human glioma cell lines. Int J Oncol (1996) 0.77
The noncoding and surface envelope coding sequences of myeloblastosis-associated virus are respectively responsible for nephroblastoma development and renal hyperplasia. J Virol (1996) 0.77
The carboxy-terminal domain of c-Myb activates reporter gene expression in yeast. Oncogene (1993) 0.76
HL-60 cells isolated for resistance to vincristine are defective in 12-O-tetradecanoylphorbol-13-acetate induced differentiation and the formation of a functional AP-1 complex. Oncol Res (1992) 0.76
v-myb transformation of Xeroderma pigmentosum human fibroblasts: overexpression of the c-Ha-ras oncogene in the transformed cells. Exp Cell Res (1991) 0.76
Transforming potential of truncated v-myb and stimulation of replication by gag-myb fusion products. Oncogene (1992) 0.76
Cooperation between the H-ras oncogene and a truncated derivative of the v-myb oncogene in transformation of hamster embryo fibroblasts. Oncogene (1992) 0.76
Alterations of the MDV oncogenic regions in an MDV transformed lymphoblastoid cell line. Mol Pathol (2002) 0.75
Inactivation of herpes simplex virus by a pregnene derivative (TX 3047). Br J Pharmacol (1981) 0.75
myb-specific probes. Nucleic Acids Res (1987) 0.75
Alteration of C-MYB DNA binding to cognate responsive elements in HL-60 variant cells. Mol Pathol (2002) 0.75
Transforming potential of the v-myb oncogene from avian myeloblastosis virus: alterations in the oncogene product may reveal a new target specificity. Biochimie (1986) 0.75
[Existence of sequences homologous to the V-MYB oncogene in the genome of archaebacteria]. C R Acad Sci III (1985) 0.75
A cryptic transcription promoter in the myb oncogene of avian myeloblastosis virus. Virology (1986) 0.75